Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) CAO Deborah Stewart sold 15,457 shares of Aveanna Healthcare stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $5.56, for a total transaction of $85,940.92. Following the transaction, the chief accounting officer now directly owns 285,396 shares of the company's stock, valued at approximately $1,586,801.76. This represents a 5.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Aveanna Healthcare Stock Down 4.2%
Shares of NASDAQ AVAH traded down $0.22 during midday trading on Thursday, reaching $5.03. 287,716 shares of the stock were exchanged, compared to its average volume of 323,155. The firm has a market cap of $981.32 million, a price-to-earnings ratio of -14.79 and a beta of 2.03. The firm has a 50-day simple moving average of $5.09 and a two-hundred day simple moving average of $4.93. Aveanna Healthcare Holdings Inc. has a twelve month low of $2.32 and a twelve month high of $6.19.
Wall Street Analyst Weigh In
AVAH has been the subject of a number of recent analyst reports. Truist Financial dropped their price objective on Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating for the company in a report on Friday, April 11th. UBS Group boosted their price target on Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a report on Friday, May 9th.
View Our Latest Research Report on AVAH
Institutional Trading of Aveanna Healthcare
Several institutional investors have recently modified their holdings of AVAH. Banque Transatlantique SA purchased a new position in shares of Aveanna Healthcare in the first quarter worth about $25,000. KLP Kapitalforvaltning AS acquired a new stake in Aveanna Healthcare in the 4th quarter valued at about $35,000. BNP Paribas Financial Markets acquired a new stake in Aveanna Healthcare in the 4th quarter valued at about $35,000. Tower Research Capital LLC TRC lifted its stake in Aveanna Healthcare by 662.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock worth $36,000 after purchasing an additional 6,854 shares in the last quarter. Finally, Catalyst Funds Management Pty Ltd boosted its holdings in shares of Aveanna Healthcare by 321.4% during the 4th quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock worth $54,000 after purchasing an additional 9,000 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.
Aveanna Healthcare Company Profile
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
See Also
Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
